Sarafloxacin-d8 (hydrochloride trihydrate)

Sarafloxacin-d8 (hydrochloride trihydrate)

• UNSPSC Description: Sarafloxacin-d8 (hydrochloride trihydrate) is the deuterium labeled Sarafloxacin hydrochloride trihydrate. Sarafloxacin hydrochloride trihydrate is a quinolone antibiotic compound[1][2].
• Target Antigen: Bacterial
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Solubility: 10 mM in DMSO
• Smiles: O=C(C1=CN(C2=CC=C(F)C=C2)C3=C(C=C(F)C(N4C([2H])([2H])C([2H])([2H])NC([2H])([2H])C4([2H])[2H])=C3)C1=O)O.Cl.O.O.O
• Molecular Weight: 483.92
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]McConville, M.L., et al., Effects of sarafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions. Vet Q, 1995. 17(1): p. 1-5.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported